EX-99.1 2 d923086dex991.htm EX-99.1

EX-99.1

EXHIBIT 99.1

INFORMATION REGARDING THE DIRECTOR AND EXECUTIVE OFFICERS OF LIGAND

PHARMACEUTICALS INCORPORATED AND METABASIS THERAPEUTICS, INC.

The names and the principal occupations of the current directors and executive officers of Ligand Pharmaceuticals Incorporated (“Ligand”) are set forth below. The business address of each of the individuals named below is c/o 11119 North Torrey Pines Road, Suite 200, La Jolla, CA 92037.

During the last five years, none of the individuals has been convicted in any criminal proceeding (excluding traffic violations and similar misdemeanors) or has been a party to any civil proceeding of a judicial or administrative body as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding violations with respect to such laws.

LIGAND
		Position with Ligand		Principal occupation		Shares of Viking Therapeutics, Inc. beneficially owned		Description of any contract, arrangement, understanding or relationship with respect to any securities of Viking Therapeutics, Inc.		Citizenship
John L. Higgins		Chief Executive Officer and Director		Chief Executive Officer and Director at Ligand Pharmaceuticals Incorporated		6,250 (1)		Not applicable		USA
Matthew W. Foehr		President and Chief Operating Officer		President and Chief Operating Officer at Ligand Pharmaceuticals Incorporated		6,250(1)		Not applicable		USA
Nishan de Silva		Vice President of Finance & Strategy and Chief Financial Officer		Vice President of Finance & Strategy and Chief Financial Officer at Ligand Pharmaceuticals Incorporated		-0-		Not applicable		USA
Charles S. Berkman		Vice President, General Counsel and Secretary		Vice President, General Counsel and Secretary at Ligand Pharmaceuticals Incorporated		-0-		Not applicable		USA
Melanie J. Herman		Director of Accounting and Chief Accounting Officer		Director of Accounting and Chief Accounting Officer at Ligand Pharmaceuticals Incorporated		-0-		Not applicable		USA

John W. Kozarich		Chairman and Director		Chairman and President of ActivX Biosciences		-0-		Not applicable		USA
Jason M. Aryeh		Director		Managing General Partner of JALAA Equities, LP		-0-		Not applicable		USA
Todd C. Davis		Director		Founding Managing Director of HealthCare Royalty Partners		-0-		Not applicable		USA
David M. Knott		Director		Chief Investment Manager, Managing Partner, and Director of Knott Partners		-0-		Not applicable		USA
John L. LaMattina		Director		Senior Partner at PureTech		-0-		Not applicable		USA
Sunil Patel		Director		Senior Vice President, Chief Business Officer at OncoMed Pharmaceuticals		-0-		Not applicable		USA
Stephen L. Sabba		Director		Bio/Pharma Analyst and Fund Manager at Knott Partners		-0-		Not applicable		USA

(1) Includes shares underlying an option which has vested or will vest within 60 days of the date hereof.